--- title: "\"Performance\" CF PHARMTECH's annual net profit is 2.485 million RMB, down 88.2%" type: "News" locale: "en" url: "https://longbridge.com/en/news/280983391.md" description: "CF PHARMTECH announced its full-year results for the year ended December last year, with a revenue of RMB 433 million, a year-on-year decrease of 28.8%. The net profit was RMB 2.485 million, a year-on-year decrease of 88.2%; earnings per share were 0.66 cents. No dividend was declared. Under non-International Financial Reporting Standards, the adjusted profit last year fell by 38.8% to RMB 31.751 million" datetime: "2026-03-30T08:33:14.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280983391.md) - [en](https://longbridge.com/en/news/280983391.md) - [zh-HK](https://longbridge.com/zh-HK/news/280983391.md) --- # "Performance" CF PHARMTECH's annual net profit is 2.485 million RMB, down 88.2% CF PHARMTECH (02652.HK) announced its full-year results for the year ended last December, with a revenue of RMB 433 million, a year-on-year decrease of 28.8%. The net profit was RMB 2.485 million, a year-on-year decrease of 88.2%; earnings per share were 0.66 cents. No dividend was declared. Under non-International Financial Reporting Standards, the adjusted profit last year fell by 38.8% to RMB 31.751 million ### Related Stocks - [02652.HK](https://longbridge.com/en/quote/02652.HK.md) ## Related News & Research - [](https://longbridge.com/en/news/284904216.md) - [United Laboratories Sets June 2026 AGM, Seeks Fresh Share Issuance Mandate](https://longbridge.com/en/news/284525414.md) - [RFK Jr.'s New Autism Committee Issues First Proposals](https://longbridge.com/en/news/284480897.md) - [Pharmaron Beijing Issues Unaudited First-Quarter 2026 Report Under Hong Kong Rules](https://longbridge.com/en/news/284364965.md) - [LEO Pharma to acquire gene therapy company Replay](https://longbridge.com/en/news/284878627.md)